FOI release

FOI request yellow card reports

Case reference FOI2025/00091

Received 3 February 2025

Published 25 April 2025

Request

I am looking to submit a freedom of information request regarding the MHRA yellowcard scheme. Specifically, I am looking to determine: (1) The number of adverse events reported for any class of GLP-1 inhibitor injection (Mounjaro, Trulicity, Victoza, Ozempic and Wegovy) from January 1st 2023, to December 31st 2024, broken down by primary complaint/issue/reason for reporting, and… (2) The number of adverse events for any of the above medicines which were reported by the marketing authorisation holder specifically, as opposed to a member of the public or healthcare professional, over the same period of time (January 1st 2023 to December 31st 2024).

Response

see attached

Documents

• FOI2025_00091 DAP.pdf (561.3 KB)
• FOI2025_00091 redacted for publication.pdf (105.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.